Cargando…
CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data
Breast cancer patients with residual disease after neoadjuvant chemotherapy and surgery may benefit from additional anti-cancer therapies. Capecitabine, an oral antimetabolite and prodrug of 5-Flurouracil, has been approved for treating metastatic breast cancer. One randomized clinical trial (CREATE...
Autores principales: | Zujewski, Jo Anne, Rubinstein, Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519731/ https://www.ncbi.nlm.nih.gov/pubmed/28758147 http://dx.doi.org/10.1038/s41523-017-0029-3 |
Ejemplares similares
-
Changing Paradigms in Breast Cancer Therapeutics: An Extended Abstract
por: Zujewski, Jo Anne
Publicado: (2016) -
Creating an ethics curriculum using a structured framework
por: Cheung, Lawrence
Publicado: (2017) -
AJEDI in Science: Leveraging Instructor Communities to Create Antiracist Curricula
por: Miller, Sarah, et al.
Publicado: (2022) -
Ten Simple Rules for Creating a Good Data Management Plan
por: Michener, William K.
Publicado: (2015) -
Capecitabine from X-ray powder synchrotron data
por: Rohlicek, Jan, et al.
Publicado: (2009)